title: Is combination second-line therapy in rheumatoid arthritis more aggressive than helpful?
authors.affiliation: Rheumatology Department, Brest Teaching Hospital, France.
authors.forename: J M
authors.initials: JM
authors.lastname: Berthelot
authors.forename: A
authors.initials: A
authors.lastname: Saraux
authors.forename: Y
authors.initials: Y
authors.lastname: Maugars
authors.forename: A
authors.initials: A
authors.lastname: Prost
authors.forename: P
authors.initials: P
authors.lastname: Le Goff
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D018849:Controlled Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D015201:Meta-Analysis as Topic
chemical_list: D018501:Antirheumatic Agents; D005938:Glucocorticoids